Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles C J Carpenter

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Universal access to antiretroviral therapy: when, not ifCharles C J Carpenter
The New England Journal of Medicine|May 30, 2003
Fusion inhibition--a major but costly step forward in the treatment of HIV-1Karen T Tashima, Charles C J Carpenter
Medicine and Health, Rhode Island|August 19, 2009
Introduction: HIVCharles C J Carpenter, Erna Milunka Kojic
The New England Journal of Medicine|February 25, 2006
Public health principles for the HIV epidemicTimothy P Flanigan, Curt Beckwith, Charles C J Carpenter
Health Affairs (Project Hope)|July 11, 2012
Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are neededKartik K Venkatesh, Kenneth H Mayer, Charles C J Carpenter
HIV Clinical Trials|February 1, 2005
Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimensLinda L Bausserman, Karen T Tashima, Melissa DiSpigno, et al.
Transactions of the American Clinical and Climatological Association|September 22, 2009
HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicineTimothy P Flanigan, Nickolas Zaller, Lynn Taylor, et al.
The Lancet. Infectious Diseases|November 1, 2002
Monitoring HIV treatment in the developing worldN Kumarasamy, Timothy P Flanigan, Anish P Mahajan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapyN Kumarasamy, Snigdha Vallabhaneni, Anitha J Cecelia, et al.
AIDS (London, England)|April 2, 2005
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patientsNagalingeswaran Kumarasamy, Snigdha Vallabhaneni, Timothy P Flanigan, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 16, 2005
Universal access to antiretroviral therapy: when, not ifCharles C J Carpenter
The New England Journal of Medicine|May 30, 2003
Fusion inhibition--a major but costly step forward in the treatment of HIV-1Karen T Tashima, Charles C J Carpenter
Medicine and Health, Rhode Island|August 19, 2009
Introduction: HIVCharles C J Carpenter, Erna Milunka Kojic
The New England Journal of Medicine|February 25, 2006
Public health principles for the HIV epidemicTimothy P Flanigan, Curt Beckwith, Charles C J Carpenter
Health Affairs (Project Hope)|July 11, 2012
Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are neededKartik K Venkatesh, Kenneth H Mayer, Charles C J Carpenter
HIV Clinical Trials|February 1, 2005
Racial differences in serum lipids in HIV+ women treated with protease inhibitor regimensLinda L Bausserman, Karen T Tashima, Melissa DiSpigno, et al.
Transactions of the American Clinical and Climatological Association|September 22, 2009
HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicineTimothy P Flanigan, Nickolas Zaller, Lynn Taylor, et al.
The Lancet. Infectious Diseases|November 1, 2002
Monitoring HIV treatment in the developing worldN Kumarasamy, Timothy P Flanigan, Anish P Mahajan, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapyN Kumarasamy, Snigdha Vallabhaneni, Anitha J Cecelia, et al.
AIDS (London, England)|April 2, 2005
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patientsNagalingeswaran Kumarasamy, Snigdha Vallabhaneni, Timothy P Flanigan, et al.
Pageof 3